Johannes Gutenberg-Universität Mainz
- 6131/39-0
Decker, T.; Brucker, C.; Engel, A. et al.
Treatment of elderly patients (pts; > 75 years) with 1st line ribociclib (RIB) plus aromatase inhibitor (AI)/fulvestrant (FUL) or endocrine monotherapy (ET) in clinical routine: Real-world data from the RIBANNA study (5th interim analysis (IA))ONCOLOGY RESEARCH AND TREATMENT. Bd. 46. 2023 S. 168-169
Decker, T.; Brucker, C.; Fasching, P. et al.
Treatment of elderly patients (pts; > 75 years) with 1st-line ribociclib (RIB) plus endocrine therapy (ET) or endocrine monotherapy in clinical routine: Real-world data from the RIBANNA study (5th interim analysis (IA))ANNALS OF ONCOLOGY. Bd. 34. 2023 S. S354-S355
Beyzaee, Amir Mohammad; Goldust, Mohammad; Patil, Anant et al.
Treatment of Frontal Fibrosing AlopeciaDERMATOLOGIC THERAPY. Bd. 2023. 2023
Yokoyama, Hiroaki; Tamm, Alexander R.; Geyer, Martin et al.
Treatment of severe aortic valve regurgitation with the Trilogy TAVI systemEUROINTERVENTION. Bd. 18. H. 17. 2023 S. 1444-1445
Roth, Klaus Edgar; Simons, Paul; Egermann, Markus et al.
Treatment of symptomatic end-stage osteoarthritis of the ankle with anterolateral approach and an anatomical plateOPERATIVE ORTHOPADIE UND TRAUMATOLOGIE. 2023
Roser, Eva; Harter, Philipp; Zocholl, Dario et al.
Treatment strategies in patients with gynecological sarcoma: Results of the prospective intergroup real-world registry for gynecological sarcoma in Germany (REGSA-NOGGO RU1)INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER. 2023
Venken, Koen; Decruy, Tine; Sparwasser, Tim et al.
Tregs protect against invariant NKT cell-mediated autoimmune colitis and hepatitisIMMUNOLOGY. 2023
Jain, Aarti Kishore; Tansey, Ginger; Hartig, Renee et al.
Trends and Treatment Approaches for Complications in Neuroscience Experiments with Monkey SpeciesCOMPARATIVE MEDICINE. Bd. 73. H. 3. 2023 S. 216-228
Schmidt, Kai-Helge; Milger, Katrin; Pausch, Christine et al.
Trends in COVID-19-associated mortality in patients with pulmonary hypertension: a COMPERA analysisEUROPEAN RESPIRATORY JOURNAL. Bd. 61. H. 4. 2023
Lee, Keun-Wook; Moehler, Markus H.; Cunningham, David et al.
Trial in progress: A phase 2, multicenter, open-label study of DKN-01 in combination with tislelizumab and chemotherapy as 1L therapy in patients with unresectable, locally advanced or metastatic gastric or gastroesophageal junction adenocarcinoma (G/GEJ; DisTinGuish).JOURNAL OF CLINICAL ONCOLOGY. Bd. 41. 2023 S. TPS484-TPS484